Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Jin-Seok Ahn"'
Autor:
J.H. Lim, Sungkeun Shim, Eunjee Kang, Heesu Nam, Mangyeong Lee, Junghee Yoon, Sang-Won Lee, Danbee Kang, Youngha Kim, Soo-Yong Shin, Jin Seok Ahn, Sooyeon Kim, Haesook Bok, Dongryul Oh, Juhee Cho
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 (K-PROMIS-29 V2.1) among cancer survivors. Materials and methods Participants were recruited from outpatie
Autor:
Jeeyun Lee, Jong Mu Sun, Seokuee Kim, Jin Seok Ahn, Jung-Ryul Kim, Sujong Kim, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park, Rae O. Han, Myung-Ju Ahn
Publikováno v:
Expert Opinion on Investigational Drugs. 29:1059-1067
We evaluated the tolerability, pharmacokinetics (PK) and preliminary efficacy of KML001, an oral trivalent arsenical, as a monotherapy in patients with advanced solid tumors.With a standard 3 + 3 design for dose-escalation stage, the planned dose lev
Autor:
Tae Hee Hong, Keunchil Park, Myung-Ju Ahn, Hyun-Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Yoon-La Choi, Sehhoon Park, Soohyun Hwang, Jong-Mu Sun
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: A certain proportion of non-small cell lung cancer (NSCLC) with activating EGFR mutations showed resistance to tyrosine kinase inhibitors (TKIs) by transforming their histology into small cell lung cancer (SCLC). In this study, we evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3968a3d226fdc699056ea617daf9ea
https://europepmc.org/articles/PMC8674595/
https://europepmc.org/articles/PMC8674595/
Autor:
Mangyeong, Lee, Danbee, Kang, Sooyeon, Kim, Jihyun, Lim, Junghee, Yoon, Youngha, Kim, Sungkeun, Shim, Eunji, Kang, Jin Seok, Ahn, Juhee, Cho, Soo-Yong, Shin, Dongryul, Oh
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(1)
This study aims to identify factors associated with the adoption and compliance of electronic patient-reported outcome measure (ePROM) use among cancer patients in a real-world setting.This prospective cohort study was conducted at the Samsung Medica
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We tried to evaluate whether there are any specific features in treatment outcomes of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), compared with gefitinib or erlotinib.
Autor:
Richard Chye, Jin Seok Ahn, Kristal Cielo Buemio, Mariana Palladini, Brian Le, Hayati Yaakup, Henry Lu, Yu Yun Shao, Gabriel Olarte, Amar Salti, Yacine Hadjiat, Tony O'Brien, Consuelo Gutierrez Colin
Publikováno v:
Journal of Opioid Management. 15:147-158
Transdermal buprenorphine (TDB) has demonstrated effectiveness in treating a range of chronic pain conditions, including cancer pain, nociceptive pain, and neuropathic pain and has a favorable safety profile. Worldwide, clinical experience of its use
Autor:
Yeon Hee Park, Soo Youn Cho, Eun Yoon Cho, Seok Jin Nam, Young-Hyuck Im, Jin Seok Ahn, Youjeong Seo
Publikováno v:
Journal of Breast Cancer
Purpose PIK3CA mutation is considered to be a possible cause for resistance to neoadjuvant chemotherapy (NAC) in human epidermal growth factor receptor 2 (HER2)-positive breast cancer. We investigated the association between PIK3CA mutations and the
Autor:
Hyun Ae Jung, Myung-Ju Ahn, Jong-Mu Sun, Se-Hoon Lee, Keunchil Park, Sook Young Woo, Jin Seok Ahn
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Brain metastasis is common in non-small cell lung cancer (NSCLC) and has an even higher incidence in epidermal growth factor receptor (EGFR)-mutant cancers. Although EGFR tyrosine kinase inhibitors (TKIs) are effective against brain metas
Autor:
Mison Chun, Danbee Kang, Ka Ryeong Bae, Jae Yoon Yi, Im-Ryung Kim, Jaesung Heo, Young Mog Shim, Sun-Seog Kweon, Juhee Cho, Yeojin Ahn, Jin Seok Ahn, Seok Jin Nam
Publikováno v:
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100633-(2020)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Purpose This study describes the protocol for the design and evaluation of a self-assessment based educational program supporting cancer patients’ return-to-work (RTW), prior to its complete and ongoing implementation. Methods We designed a multi-c
Autor:
Myung-Ju Ahn, Jin Seok Ahn, Se-Hoon Lee, Keunchil Park, Hyunchul Jung, Jong-Mu Sun, Kwoneel Kim, Jung Kyoon Choi, Hong Sook Kim, Jeong Yeon Kim
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Nature Communications
Nature Communications
Neoantigen burden is regarded as a fundamental determinant of response to immunotherapy. However, its predictive value remains in question because some tumours with high neoantigen load show resistance. Here, we investigate our patient cohort togethe